Dexin China’s $190 Million Initial Public Offering

O’Melveny recently represented Dexin China Holdings Company Limited in its US$190 million initial public offering on the Main Board of the Hong Kong Stock Exchange (2019.HK)….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here